Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
about
Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)Leveraging fluorinated glucosamine action to boost antitumor immunityLeukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flowRegulation of the metastatic cell phenotype by sialylated glycansSelectins mediate small cell lung cancer systemic metastasisCirculating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flowCD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditionsMac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cellsGlycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systemsKnockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesionExtracellular protein disulfide isomerase regulates ligand-binding activity of αMβ2 integrin and neutrophil recruitment during vascular inflammationHuman fucosyltransferase 6 enables prostate cancer metastasis to boneNeutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammationCopper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.Novel serum proteomic signatures in a non-human primate model of retinal injurySystemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model.Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4.Glycosylation potential of human prostate cancer cell lines.Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.Real-time imaging of heterotypic platelet-neutrophil interactions on the activated endothelium during vascular inflammation and thrombus Formation in live mice.The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.Physiological contribution of CD44 as a ligand for E-Selectin during inflammatory T-cell recruitment.PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation.Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.The emerging importance of α-L-fucose in human breast cancer: a review.Protein glycoengineering enabled by the versatile synthesis of aminooxy glycans and the genetically encoded aldehyde tagCD44 and HCELL: preventing hematogenous metastasis at step 1.Protein glycosylation in cancer.Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands.Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation.Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways?E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangiomaComputational and experimental models of cancer cell response to fluid shear stress.Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes.TRAIL-coated leukocytes that kill cancer cells in the circulation.Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells.Altered tumor-cell glycosylation promotes metastasis.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
P2860
Q26739942-F8FE83A8-727C-4C95-907B-405C52E29DDDQ27008230-AE0A01D2-55AC-491D-841C-D17DB467E2E5Q27027232-3FD27AE6-3A25-472C-83FA-24CFF8C536B4Q27027559-616A66FD-0344-45EF-9648-222C5D8FC02AQ27314565-2B7C353A-FB51-4648-9B7B-0C321D14A3A6Q27334142-4F0ECBDD-0F8F-4615-861F-CA645941AD0EQ28250164-25C336CA-0DFB-49B3-8DB9-FB38219AF7B3Q28274894-E54BB5F3-61C6-4032-A101-7F19C9768668Q28475586-B4641C95-626D-4F71-A83F-34925BA05C0FQ30497537-BFEED225-9E7E-4771-B0CC-258FBF90EECCQ30539687-31995D25-9D13-4B54-A389-D390CD788E82Q30559315-10A92E2C-5CDE-426A-B75D-70F4B9ABF84CQ30575274-6CAD68A2-79E0-4074-9A7C-9D2531CCFA76Q30666915-6E9B3CD2-4F84-4AAE-A422-3A14C8EDE9E2Q31007957-FF3BF2D2-39DA-4186-8D68-B2008F9F8CC1Q33727882-CE801C39-4FF7-4597-8B38-6F5C43F0AB6FQ33855700-FB27AA57-50E0-4C38-BEF3-2BE39355E203Q34046293-B25F3119-3BDA-4D57-8551-7F56E3459D8EQ34192497-F459DF51-BC8B-40A9-BB64-8EA0017E9A0DQ34681262-E26F2851-C953-4754-8345-0923D12094C6Q34784896-D424349B-E7EF-48B6-B18C-3380EA939885Q34839368-14BA49CF-55F6-4D23-8248-9C1C7C5BDE0DQ34972318-96CA3F08-D337-4FC6-9398-5D63FDFE8A47Q35065252-0FAE50B0-5364-4C1F-AA4E-03DE1D45143AQ35069229-F82F2050-AE12-471E-9F8F-0CED3A0A5B6DQ35172546-81CD9CF4-8F3A-4854-9B88-E2BCE920910AQ35276443-6B8401E2-CE3B-4E34-9191-207099EA6716Q35376738-C82BD26D-821E-4087-9133-74C92E648C41Q35413473-3B1D556D-3109-4363-9C89-0B444DA1A722Q35899406-76DC1E63-DFC5-486D-B3FC-2C441C676F00Q36134014-183BE746-1009-4A3C-8CD9-9974210009B9Q36175119-31A038B7-EBA1-4DB9-BCF5-9366F14538CFQ36433043-8E2EC9C0-F6BA-46FD-B6C6-EA38C1224824Q36655350-E3D4BCE5-06C8-4CD8-AEEE-307E96329D6EQ36970387-3FEA458D-12FC-438C-85AB-AF4EA4B41179Q37519654-8CE38F74-0515-4F5D-AB96-D6A5B42CF763Q37575305-45163B84-A338-4BFA-A3D2-4B1EC332A669Q37581540-534E058B-366A-470C-A537-28895A7DC5A1Q37615286-072A2E89-8C50-4015-9238-890A202E5C5AQ37672628-6AC6C358-C785-46C4-AA71-A0EDBAC0C5A7
P2860
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
@ast
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
@en
type
label
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
@ast
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
@en
prefLabel
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
@ast
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.
@en
P2093
P2860
P356
P1476
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking
@en
P2093
Bruce Furie
Charles J Dimitroff
Danielle L Hays
Georg K Wiese
Jaehyung Cho
Javed Siddiqui
Matthew J Opperman
Steven R Barthel
P2860
P304
19491-19496
P356
10.1073/PNAS.0906074106
P407
P577
2009-11-04T00:00:00Z